Combined radiation and p53 gene therapy of malignant glioma cells

Cancer Gene Therapy

Volumn 6, Issue 2, 1999, Pages 155-162

  Badie, Behnam ^a,c   Goh, Chern Sing ^a   Klaver, Jessica ^a   Herweijer, Hans ^b   Boothman, David A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Adenoviral vectors; Brain neoplasm; Gene therapy; Glioma; p53; Radiation

Indexed keywords

BAX PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL NUCLEUS; FLOW CYTOMETRY; GENE THERAPY; GENE VECTOR; GENETICS; GLIOMA; HUMAN; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RADIATION RESPONSE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOVIRIDAE; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CYCLE; CELL NUCLEUS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; GENE THERAPY; GENES, P53; GENETIC VECTORS; GLIOMA; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033090071     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700009     Document Type: Article

References (30)

1. Greenblatt M, Bennett W, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-4878.
2. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991;253:49-53.
3. Louis D, von Deimling A, Chung R, et al. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol. 1993;52:31-38.
4. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF-1, a potential mediator of p53 tumor suppression. Cell. 1993; 75:817-825.
5. Xiong Y, Khang H, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701-704.
6. Smith ML, Chen IT, Zhan Q, et al. Interaction of the p53-regulated protein GAAD45 with proliferating cell nuclear antigen. Science. 1994;266:1376-1380.
7. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1809.
8. MacIlwrath AJ, Vasey PA, Ross GM, et al. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res. 1994;54:3718-3722.
9. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 1993;53:4164-4168.
10. Smith ML, Chen IT, Zhan Q, et al. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene. 1995;10:1053-1059.
11. Gotz C, Montenarh M. p53: DNA damage, DNA repair, and apoptosis. Rev Physiol Biochem Phannacol. 1995;127: 65-95.
12. Badie B, Drazan KE, Kramar MH, et al. Adenovirus-mediated p53 gene delivery inhibits glioma growth in rats. Neurol Res. 1995;17:209-216.
13. Badie B, Kramar MH, Lau R, et al. Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. J Neurooncol. 1998;37:217-222.
14. Gjerset RA, Turia ST, Sobol RE, et al. Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53. Mol Carcinog. 1995;14:275-285.
15. Gomez-Manzano C, Fueyo J, Kyritsis AP, et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 1996;56:694-699.
16. Köck H, Harris M, Anderson S, et al. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer. 1996;67: 808-815.
17. Badie B, Hunt K, Economou JS, et al. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery. 1994;35:910-916.
18. Michieli P, Chedid M, Lin D, et al. Induction of WAF1/ CIP1 by a p53-independent pathway. Cancer Res. 1994;54: 3391-3395.
19. Kuerbitz SJ, Plunkett BS, Walsh WV, et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA. 1992;89:7491-7495.
20. Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847-849.
21. Fujiwara T, Grimm EA, Mukhopadhyay T, et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 1994;54:2287-2291.
22. Hamada K, Alemany R, Zhang W-W, et al. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res. 1996;56:3047-3054.
23. Ko S-C, Gotoh A, Thalmann GN, et al. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Hum Gene Ther. 1996;7:1683-1691.
24. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995;55:1-6.
25. Liu T-J, El-Naggar AK, McDonnell TJ, et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 1995;55:3117-3122.
26. Dee S, Haas-Kogan D, Israel M. Inactivation of p53 is associated with decreased levels of radiation-induced apoptosis in medulloblastoma cell lines. Cell Death Different. 1995;2:267-275.
27. Akashi M, Hachiya M, Osawa Y, et al. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem. 1995;270:19181-19187.
28. Fuchs E, McKenna K, Bedi A. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32β. Cancer Res. 1997;57:2550-2554.
29. 1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys. 1996;36:95-103.
30. Yount GL, Haas-Kogan DA, Vidair CA, et al. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res. 1996;56:500-506.